03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Pentoxifylline SR° : | |
Type | Medicine Withdrawn |
Originator | Trental Tablets |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | C04AD03 |
Apo-Pentoxifylline SR° :
Apo-Pentoxifylline SR° :
Apo-Pentoxifylline SR° :
Apo-Pentoxifylline SR° :
Apo-Pentoxifylline SR° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Pentoxifylline SR° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agitation | Uncommon |
Anaphylactic reactions | Very rare |
Anaphylactoid reactions | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Bronchospasm | Very rare |
Cephalea | Uncommon |
Diarrhoea (Diarrhea) | Common |
Failure circulatory | Very rare |
Flushing skin | Common |
Intrahepatic cholestatis | Very rare |
Nausea | Common |
Pruritus | Uncommon |
Sensation of fullness | Common |
Sensation of heat (Feeling of warmth) (Sensation of warmth) | Common |
Skin flushed | Uncommon |
Sleep disorder (Sleep disturbance) | Uncommon |
Stomach heaviness | Common |
Tachycardia | Uncommon |
Thrombocytopenia (Thrombopenia) | Very rare |
Transaminases increased | Very rare |
Urticaria | Uncommon |
Vertigo | Uncommon |
Vomiting | Common |
Apo-Pentoxifylline SR° :
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Pentoxifylline SR° MoH 5739 :
Form | Tablet, sustained release |
Packaging | Bottle |
Package Size | Box of 100 |
Strength | 400mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 219529/09 |
Submission date | 01/01/2009 |
Registration Year | 2010 |
Withdrawn Date | 13/06/2024 |
Price Comparison
● Country: | UK |
● Package Size: | 90 |
● Reference: | DMD |
● Pricing Date: | 08/03/2021 |
● Type: | Medicine Withdrawn |
You have to register to view this info
Drop File